Valuation Acarix AB Deutsche Boerse AG
Stocks
7AC
SE0009268717
Advanced Medical Equipment & Technology
|
Delayed
Deutsche Boerse AG
02:02:16 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.0141 EUR | 0.00% |
|
+3.68% | -18.02% |
| 08-13 | Acarix AB, Q2 2026 Earnings Call, Aug 13, 2026 | |
| 08-13 | Acarix AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: Acarix AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 219.7 | 71.81 | 139.9 | 267 | 332.5 | 297.7 | - | - |
| Change | - | -67.32% | 94.84% | 90.83% | 24.52% | -10.45% | - | - |
| Enterprise Value (EV) | 203.9 | 60.65 | 139.9 | 267 | 332.5 | 297.7 | 297.7 | 297.7 |
| Change | - | -70.25% | 130.69% | 90.83% | 24.52% | -10.45% | 0% | 0% |
| P/E | -2.36x | - | -1.19x | -3.59x | - | - | - | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | 0.1x | - | - | - | - |
| Capitalization / Revenue | 58.4x | 12.3x | 22.4x | 43.1x | 45.2x | 21.3x | 9.3x | 2.94x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 21.3x | 9.3x | 2.94x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -10.9x | -22.7x | 9.16x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -9.83x | -19.5x | 11.3x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.37 | - | -0.16 | -0.07 | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 3.76 | 5.822 | 6.241 | 6.202 | 7.361 | 14 | 32 | 101.3 |
| EBITDA 1 | -48.32 | -73.44 | -74.46 | -63.08 | -44.54 | -27.3 | -13.1 | 32.5 |
| EBIT 1 | -51.7 | -76.48 | -77.55 | -66.37 | -48.01 | -30.3 | -15.3 | 26.4 |
| Net income 1 | -51.73 | -76.98 | -77.84 | -66.19 | -40.84 | -30.8 | -15.3 | - |
| Net Debt | -15.86 | -11.16 | - | - | - | - | - | - |
| Reference price 2 | 0.8720 | 0.2850 | 0.1898 | 0.2510 | 0.2680 | 0.2400 | 0.2400 | 0.2400 |
| Nbr of stocks (in thousands) | 251,972 | 251,972 | 737,189 | 1,063,744 | 1,240,557 | 1,240,512 | - | - |
| Announcement Date | 2/17/22 | 2/16/23 | 2/15/24 | 2/13/25 | 2/12/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 65.7x | 5.1x | 17.05x | 0.32% | 17.96B | ||
| 38.45x | - | - | 2.1% | 1.66B | ||
| -3.72x | 1.48x | 6.85x | - | 1.05B | ||
| 16.08x | 2.23x | 7.55x | 1.6% | 959M | ||
| 48.98x | - | - | - | 779M | ||
| 148.37x | - | - | 0.6% | 565M | ||
| 39.68x | 2.86x | 18.77x | 1.03% | 461M | ||
| -11.89x | - | - | - | 459M | ||
| Average | 42.71x | 2.92x | 12.55x | 1.13% | 2.99B | |
| Weighted average by Cap. | 58.18x | 4.73x | 16.12x | 0.54% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ACARIX Stock
- 7AC Stock
- Valuation Acarix AB
Select your edition
All financial news and data tailored to specific country editions
















